DSM to Close Clavulanic Acid Site in Sweden

DSM Anti-Infectives, a DSM subsidiary, will close a clavulanic acid production site at Strängnäs, Sweden. Clavulanic acid is used in the formulation of certain antibiotics. The site will cease operating toward the end of 2009 with the loss of about 100 jobs. The closure will cost DSM just over €10 million ($14 million). “It is not possible to maintain a profitable manufacturing activity for the product in Sweden,” says Jan Zuidam, vice chairman of...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers